Market Research Logo

Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022

Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022

“Global liquid biopsy market projected to grow at a CAGR of 23.4%”
The global liquid biopsy market is estimated to grow at a CAGR of 23.4% from 2017 to 2022, to reach USD 2,047.9 million by 2022. Increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D are some of the key factors driving the growth of the market. Unclear Regulatory and reimbursement scenario is one of the major challenges faced by the market.

“Extracellular vesicles to register the highest CAGR during the forecast period”
Based on circulating biomarkers the market is categorized into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs) and other circulating biomarkers. The extracellular vesicles segment is the fastest-growing segment in the circulating biomarkers market during the forecast period. This is due to the growing interest in EV research from biofluids such as the blood and urine of cancer patients as a means of disease diagnosis and therapeutic monitoring.

“The non-cancer application segment is projected to grow at the highest CAGR during the forecast period”
Based on application, the liquid biopsy market is segmented into cancer and non-cancer applications (which include reproductive health and organ transplant diagnostics). The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period. This is due to the growing application in noninvasive prenatal testing (NIPT), using cell-free DNA assays in the identification of trisomies (which includes 13, 16, and 18), gender identification, and other genetic abnormalities such as monosomy X and microdeletions. NIPT is also rapidly replacing amniocentesis in high-risk pregnancies, thus expanding its application.

“Asia Pacific to witness the highest growth during the forecast period (2017–2022)”
North America is expected to account for the largest share of the global liquid biopsy market in 2017, while Asia Pacific is expected to witness the highest growth during 2017 to 2022. Growing demand for non-invasive treatment, rising incidence of cancer, and improving healthcare infrastructure are driving the growth of the liquid biopsy market.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1– 15%, Tier 2– 45%, and Tier 3–40%
• By Designation – C-level– 27%, Director Level–33%, Others–40%
• By Region – North America–25%, Europe–45%, Asia-Pacific–15%, RoW–15%

Some of the major market players in the liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDxHealth SA (US).

Research Coverage:
The report analyzes the liquid biopsy market and aims at estimating market size and future growth potential of this market based on various segments such as by product, circulating biomarker, clinical application, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global liquid biopsy market. The report analyzes the global liquid biopsy market by product, medical specialty, application, end user, and region
• Innovation: Detailed insights on upcoming trends and product launches in the global liquid biopsy market
• Market Development: Comprehensive information on the lucrative emerging markets by product, medical specialty, application, end user, and region
• Market Diversification: Exhaustive information about growing geographies, recent developments, and investments in the global liquid biopsy market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and capabilities of liquid biopsy devices of leading players in the global market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH APPROACH
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • LIQUID BIOPSY: MARKET OVERVIEW
    • LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION (2017)
    • LIQUID BIOPSY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • LIQUID BIOPSY MARKET: GEOGRAPHIC MIX
    • LIQUID BIOPSY MARKET: ESTABLISHED VS. EMERGING MARKETS
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table CONFERENCES AND AWARENESS PROGRAMS ON LIQUID BIOPSY
        • Table LIQUID BIOPSY PRODUCTS LAUNCHED IN RECENT YEARS
        • Table LIQUID BIOPSY MARKET: FUNDING (2014 - 2017)
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • LIQUID BIOPSY MARKET, BY PRODUCT AND SERVICE
    • INTRODUCTION
      • Table COMPANIES SELLING/DEVELOPING LIQUID BIOPSY TESTS FOR ONCOLOGY, IN THE US
      • Table LIQUID BIOPSY MARKET, BY PRODUCT AND SERVICE, 2015–2022 (USD MILLION)
    • ASSAY KITS
      • Table LIQUID BIOPSY MARKET FOR ASSAY KITS, BY COUNTRY, 2015–2022 (USD MILLION)
    • INSTRUMENTS
      • Table SPECIFICATIONS: NGS AND DDPCR FOR CANCER LIQUID BIOPSIES
      • Table LIQUID BIOPSY MARKET FOR INSTRUMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
    • SERVICES
      • Table LIQUID BIOPSY MARKET FOR SERVICES, BY COUNTRY, 2015–2022 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER
    • INTRODUCTION
      • Table ADVANTAGES AND LIMITATIONS OF CTCS, CTDNA, AND EXOSOMES
      • Table LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2015–2022 (USD MILLION)
    • CIRCULATING TUMOR CELLS
      • Table COMPANIES ACTIVE IN THE CTCS SEGMENT
      • Table LIQUID BIOPSY MARKET FOR CIRCULATING TUMOR CELLS, BY COUNTRY, 2015–2022 (USD MILLION)
    • CIRCULATING TUMOR DNA (CTDNA)
      • Table LIQUID BIOPSY MARKET FOR CIRCULATING TUMOR DNA, BY COUNTRY, 2015–2022 (USD MILLION)
    • CELL-FREE DNA
      • Table LIQUID BIOPSY MARKET FOR CELL-FREE DNA, BY COUNTRY, 2015–2022 (USD MILLION)
    • EXTRACELLULAR VESICLES (EVS)
      • Table LIQUID BIOPSY MARKET FOR EXTRACELLULAR VESICLES, BY COUNTRY, 2015–2022 (USD MILLION)
    • OTHER CIRCULATING BIOMARKERS
      • Table LIQUID BIOPSY MARKET FOR OTHER CIRCULATING BIOMARKERS, BY COUNTRY, 2015–2022 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
    • EARLY CANCER SCREENING
      • Table LIQUID BIOPSY MARKET FOR EARLY CANCER SCREENING, BY COUNTRY/REGION, 2015–2022 (USD THOUSANDS)
    • THERAPY SELECTION
      • Table LIQUID BIOPSY MARKET FOR THERAPY SELECTION, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
    • TREATMENT MONITORING
      • Table LIQUID BIOPSY MARKET FOR TREATMENT MONITORING, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
    • RECURRENCE MONITORING
      • Table LIQUID BIOPSY MARKET FOR RECURRENCE MONITORING, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY APPLICATION
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
    • CANCER APPLICATIONS
      • Table LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • Table LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
      • LUNG CANCER
        • Table LIQUID BIOPSY MARKET FOR LUNG CANCER, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • BREAST CANCER
        • Table LIQUID BIOPSY MARKET FOR BREAST CANCER, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • COLORECTAL CANCER
        • Table LIQUID BIOPSY MARKET FOR COLORECTAL CANCER, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • PROSTATE CANCER
        • Table LIQUID BIOPSY MARKET FOR PROSTATE CANCER, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • LIVER CANCER
        • Table LIQUID BIOPSY MARKET FOR LIVER CANCER, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • OTHER CANCERS
        • Table LIQUID BIOPSY MARKET FOR OTHER CANCERS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
    • NON-CANCER APPLICATIONS
      • Table LIQUID BIOPSY MARKET FOR NON-CANCER APPLICATIONS, BY COUNTRY/REGION, 2015– 2022 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY END USER
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
    • REFERENCE LABORATORIES
      • Table LIQUID BIOPSY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
    • HOSPITALS AND PHYSICIAN LABORATORIES
      • Table LIQUID BIOPSY MARKET FOR HOSPITALS AND PHYSICIAN LABORATORIES, BY COUNTRY/ REGION, 2015–2022 (USD MILLION)
    • ACADEMIC AND RESEARCH CENTERS
      • Table LIQUID BIOPSY MARKET FOR ACADEMIC AND RESEARCH CENTERS, BY COUNTRY/ REGION, 2015–2022 (USD MILLION)
    • OTHER END USERS
      • Table LIQUID BIOPSY MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY REGION
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET, BY REGION, 2015–2022 (USD MILLION)
    • NORTH AMERICA
      • Table ESTIMATED NEW CASES OF CANCER IN 2017, US
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • US
        • Table US: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table US: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table US: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table US: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table US: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table US: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • CANADA
        • Table OVERVIEW OF THE BREAST, CERVICAL, AND COLORECTAL CANCER SCREENING PROGRAMS ACROSS CANADA
        • Table CANADA: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
    • EUROPE
      • Table EUROPE: LIQUID BIOPSY MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • GERMANY
        • Table GERMANY: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table GERMANY: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table GERMANY: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table GERMANY: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • FRANCE
        • Table FRANCE: KEY MARKET INDICATORS
        • Table FRANCE: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table FRANCE: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table FRANCE: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table FRANCE: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • UK
        • Table UK: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table UK: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table UK: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table UK: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table UK: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table UK: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table ROE: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ROE: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table ROE: LIQUID BIOPSY MARKET FOR CANCER APPLICATIONS, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table ROE: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table ROE: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: LIQUID BIOPSY MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LIQUID BIOPSY MARKET, BY TYPE OF CANCER, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • JAPAN
        • Table JAPAN: KEY MARKET INDICATORS
        • Table JAPAN: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table JAPAN: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table JAPAN: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table JAPAN: LIQUID BIOPSY MARKET, BY TYPE OF CANCER, 2015–2022 (USD MILLION)
        • Table JAPAN: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table JAPAN: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • CHINA
        • Table CHINA: KEY MARKET INDICATORS
        • Table CHINA: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table CHINA: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table CHINA: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table CHINA: LIQUID BIOPSY MARKET, BY TYPE OF CANCER, 2015–2022 (USD MILLION)
        • Table CHINA: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table CHINA: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • INDIA
        • Table INDIA: KEY MARKET INDICATORS:
        • Table INDIA: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table INDIA: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table INDIA: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table INDIA: LIQUID BIOPSY MARKET, BY TYPE OF CANCER, 2015–2022 (USD MILLION)
        • Table INDIA: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table INDIA: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table ROAPAC: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ROAPAC: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
        • Table ROAPAC: LIQUID BIOPSY MARKET, BY TYPE OF CANCER, 2015–2022 (USD MILLION)
        • Table ROAPAC: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
        • Table ROAPAC: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table ROW: LIQUID BIOPSY CIRCULATING BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ROW: LIQUID BIOPSY MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • Table ROW: LIQUID BIOPSY MARKET, BY TYPE OF CANCER, 2015–2022 (USD MILLION)
      • Table ROW: LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2015–2022 (USD MILLION)
      • Table ROW: LIQUID BIOPSY MARKET, BY END USER, 2015–2022 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • MARKET RANKING ANALYSIS
      • Table LIQUID BIOPSY MARKET, BY KEY PLAYER, 2016
  • COMPANY PROFILES
    • BIOCEPT, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
        • Table CHF TO USD CONVERSION RATES (2014-2016)
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • MYRIAD GENETICS, INC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • MENARINI-SILICON BIOSYSTEMS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • TROVAGENE, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • GUARDANT HEALTH, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • MDXHEALTH SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • GENOMIC HEALTH, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • RAINDANCE TECHNOLOGIES, INC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • THERMO FISHER SCIENTIFIC INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ILLUMINA, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report